Browsing: Pallas

As adults take a more serious look at GLP-1 weight-management care in 2026, this Pallas Health review examines its doctor-led telehealth model, compounded semaglutide and tirzepatide options, FDA-approved brand-name pathways, current pricing, and what consumers should compare before beginning an eligibility evaluation